IGC Pharma, Inc. Quarterly Cost of Revenue in USD from Q2 2010 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary: IGC Pharma, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2010 to Q2 2024.
IGC Pharma, Inc. Cost of Revenue for the quarter ending June 30, 2024 was $109K, a 63.7% decline year-over-year.
IGC Pharma, Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $421K, a 39.8% decline year-over-year.
IGC Pharma, Inc. annual Cost of Revenue for 2023 was $612K, a 30.5% increase from 2022.
IGC Pharma, Inc. annual Cost of Revenue for 2022 was $469K, a 131% increase from 2021.
IGC Pharma, Inc. annual Cost of Revenue for 2021 was $203K, a 74.1% decline from 2020.

Cost of Revenue, Trailing 12 Months (USD)

Cost of Revenue, Quarterly (USD)

Cost of Revenue, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$421K	$109K	-$191K	-63.7%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$612K	$124K	+$22K	+21.6%	Jan 1, 2024	Mar 31, 2024	10-K	2024-06-24
Q4 2023	$590K	$71K	-$159K	-69.1%	Oct 1, 2023	Dec 31, 2023	10-Q	2024-02-14
Q3 2023	$749K	$117K	+$50K	+74.6%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$699K	$300K	+$230K	+329%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	$469K	$102K	+$48K	+88.9%	Jan 1, 2023	Mar 31, 2023	10-K	2024-06-24
Q4 2022	$421K	$230K	+$150K	+188%	Oct 1, 2022	Dec 31, 2022	10-Q	2024-02-14
Q3 2022	$271K	$67K	+$49K	+272%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	$222K	$70K	+$19K	+37.3%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	$203K	$54K	$0	0%	Jan 1, 2022	Mar 31, 2022	10-K	2023-07-07
Q4 2021	$203K	$80K	-$14K	-14.9%	Oct 1, 2021	Dec 31, 2021	10-Q	2023-02-14
Q3 2021	$217K	$18K	-$81K	-81.8%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-01
Q2 2021	$298K	$51K	-$487K	-90.5%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-05
Q1 2021	$785K	$54K	+$41K	+315%	Jan 1, 2021	Mar 31, 2021	10-K	2022-06-23
Q4 2020	$744K	$94K	-$449K	-82.7%	Oct 1, 2020	Dec 31, 2020	10-Q	2022-02-10
Q3 2020	$1.19M	$99K	-$1.69M	-94.5%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-10-29
Q2 2020	$2.89M	$538K	-$1.07M	-66.5%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-11
Q1 2020	$3.96M	$13K	-$1.5M	-99.1%	Jan 1, 2020	Mar 31, 2020	10-K	2021-06-14
Q4 2019	$5.46M	$543K	-$697K	-56.2%	Oct 1, 2019	Dec 31, 2019	10-Q	2021-02-16
Q3 2019	$6.16M	$1.79M	+$1M	+126%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-20
Q2 2019	$5.16M	$1.61M	+$172K	+12%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-19
Q1 2019	$4.98M	$1.52M	+$297K	+24.4%	Jan 1, 2019	Mar 31, 2019	10-K	2020-07-13
Q4 2018	$4.69M	$1.24M	+$517K	+71.5%	Oct 1, 2018	Dec 31, 2018	10-Q	2020-02-10
Q3 2018	$4.17M	$793K	+$630K	+387%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-06
Q2 2018	$3.54M	$1.44M	+$1.43M	+20772%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-09
Q1 2018	$2.11M	$1.22M	+$1.27M		Jan 1, 2018	Mar 31, 2018	10-K	2019-06-14
Q4 2017	$841K	$723K	+$601K	+493%	Oct 1, 2017	Dec 31, 2017	10-Q	2019-02-12
Q3 2017	$240K	$163K	+$72.5K	+80%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-16
Q2 2017	$167K	$6.88K	-$195K	-96.6%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-03
Q1 2017	$362K	-$52.1K	-$1.15M	-105%	Jan 1, 2017	Mar 31, 2017	10-K	2018-06-21
Q4 2016	$1.51M	$122K	-$757K	-86.1%	Oct 1, 2016	Dec 31, 2016	10-Q	2018-02-20
Q3 2016	$2.27M	$90.5K	-$1.8M	-95.2%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-17
Q2 2016	$4.07M	$202K	-$1.45M	-87.8%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-18
Q1 2016	$5.52M	$1.1M	-$1.03M	-48.5%	Jan 1, 2016	Mar 31, 2016	10-K	2017-07-14
Q4 2015	$6.56M	$879K	-$1.46M	-62.5%	Oct 1, 2015	Dec 31, 2015	10-Q	2017-02-21
Q3 2015	$8.02M	$1.89M	-$46.9K	-2.42%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-21
Q2 2015	$8.07M	$1.65M	+$967K	+141%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-16
Q1 2015	$7.1M	$2.13M	+$2.13M	+52741%	Jan 1, 2015	Mar 31, 2015	10-K	2016-07-14
Q4 2014	$4.97M	$2.34M	+$2.34M	+29982%	Oct 1, 2014	Dec 31, 2014	10-Q	2016-02-16
Q3 2014	$2.64M	$1.94M	+$993K	+105%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-13
Q2 2014	$1.64M	$687K	-$249K	-26.6%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-14
Q1 2014	$1.89M	$4.04K	-$1.26M	-99.7%	Jan 1, 2014	Mar 31, 2014	10-K	2015-07-14
Q4 2013	$3.15M	$7.79K	-$3.18M	-99.8%	Oct 1, 2013	Dec 31, 2013	10-Q	2015-02-12
Q3 2013	$6.33M	$943K	-$165K	-14.9%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-13
Q2 2013	$6.5M	$936K	-$1.21K	-0.13%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-14
Q1 2013	$6.5M	$1.26M	-$654K	-34.2%	Jan 1, 2013	Mar 31, 2013	10-K	2014-07-15
Q4 2012	$7.15M	$3.19M	+$2.17M	+211%	Oct 1, 2012	Dec 31, 2012	10-Q	2014-02-14
Q3 2012	$4.99M	$1.11M	+$205K	+22.7%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-08
Q2 2012	$4.78M	$937K	-$36.9K	-3.78%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-16
Q1 2012	$4.82M	$1.92M	+$1.05M	+122%	Jan 1, 2012	Mar 31, 2012	10-K/A	2014-07-15
Q4 2011	$3.76M	$1.02M	+$567K	+124%	Oct 1, 2011	Dec 31, 2011	10-Q	2013-02-13
Q3 2011	$3.2M	$904K	-$709K	-44%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-14
Q2 2011	$3.91M	$974K	-$9.07K	-0.92%	Apr 1, 2011	Jun 30, 2011	10-Q/A	2012-08-21
Q1 2011	$3.91M	$861K			Jan 1, 2011	Mar 31, 2011	10-K	2012-07-16
Q4 2010		$457K			Oct 1, 2010	Dec 31, 2010	10-Q	2012-02-16
Q3 2010		$1.61M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-18
Q2 2010		$983K			Apr 1, 2010	Jun 30, 2010	10-Q	2011-08-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.